Koers Repros Therapeutics Inc

Aandelen

26-01-18	Repros Announces Negative Opinion From the EMA for Enclomiphene
15-12-17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency
12-12-17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout
12-12-17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders
12-12-17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

Toevoegen aan een lijst 0 geselecteerde Om deze functie te gebruiken moet u een klant of lid zijn. Inloggen Registreren	Verschil (%)	Varia. 5d.	Varia. 1j.	Varia. 3j.	Kap.($)
REPROS THERAPEUTICS INC	-.--%	+0,74%	-	-	0
LONZA GROUP AG	-0,07%	+6,23%	+3,91%	+10,44%	50,25 mld.
REVOLUTION MEDICINES, INC.	-0,56%	+0,28%	+412,14%	+611,63%	40,39 mld.
IQVIA HOLDINGS INC.	+0,81%	+7,18%	+27,48%	-4,48%	34,38 mld.
BEONE MEDICINES AG	-1,20%	+7,42%	+27,02%	+61,49%	34,4 mld.
CELLTRION, INC.	-4,19%	-1,84%	+3,76%	+32,17%	26,32 mld.
ASCENDIS PHARMA A/S	+0,67%	+0,72%	-	-	16,64 mld.
MEDPACE HOLDINGS, INC.	-2,53%	+3,13%	+71,27%	+131,90%	16,14 mld.
EUROFINS SCIENTIFIC SE	+1,05%	+1,25%	+15,16%	+22,35%	13,71 mld.
IONIS PHARMACEUTICALS, INC.	+1,68%	+5,56%	+100,32%	+100,32%	13,75 mld.
Gemiddelde	-0,47%	+3,57%	+82,63%	+120,73%	27,33 mld.
Gewogen gemiddelde per kap.	-0,62%	+4,03%	+93,98%	+138,88%

Werknemers

Sector